Trevor Cobb
Family · Houston, TXNPI 1427606763
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,345 and has fallen 54.2% since, to $616 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$666
- GSK$562
- Sanofi$347
- Johnson & Johnson$334
- Boehringer Ingelheim$324
- Inspire Medical Systems, Inc.$272
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $666 |
| GSK | 6 | $562 |
| Sanofi | 3 | $347 |
| Johnson & Johnson | 21 | $334 |
| Boehringer Ingelheim | 8 | $324 |
| Inspire Medical Systems, Inc. | 2 | $272 |
| Nestle Healthcare Nutrition Inc. | 12 | $211 |
| Amgen(2 entities) | 8 | $191 |
| Novo Nordisk | 8 | $144 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Mylan Specialty L.p. | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $122 |
| Gilead | 1 | $116 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Biohaven Pharmaceuticals, Inc. | 1 | $112 |
| Lilly USA, LLC | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 1 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $81 |
| AstraZeneca | 4 | $77 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $67 |
| Vapotherm Inc | 1 | $66 |
| Jazz Pharmaceuticals Inc. | 1 | $63 |
| Biogen | 1 | $61 |
| Amarin Pharma, Inc. | 3 | $59 |
| Coloplast | 1 | $56 |
| Neurocrine Biosciences, Inc. | 1 | $55 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Optinose US, Inc. | 1 | $23 |
| Novartis | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Bayer | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,713 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 78 | $1,919 |
| Atorvastatin Calcium | 61 | $1,886 |
| Rosuvastatin Calcium | 24 | $1,633 |
| Pravastatin Sodium | 12 | $402 |
| Losartan Potassium | 15 | $362 |
| Lisinopril | 16 | $170 |
| Simvastatin | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.